Other/unspecified enthesopathies of lower limb, excluding foot

M13_ENTESOPATHYLOWNAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.8, M76.9 Hospital discharge: ICD-9 — 7267B\|7266F\|7266X\|7267X Cause of death: ICD-10 — M76.8, M76.9 Cause of death: ICD-9 — 7267B\|7266F\|7266X\|7267X 2 out of 7 registries used, show all original rules.	3591
4. Check minimum number of events None	3591
5. Include endpoints None	3591
6. Filter based on genotype QC (FinnGen only)	3298

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_ENTESOPATHYLOWNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M76[8-9]
HD_ICD_9	7267B\|7266F\|7266X\|7267X
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M76[8-9]
COD_ICD_9	7267B\|7266F\|7266X\|7267X
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other/unspecified enthesopathies of lower limb, excluding foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19066	11159	7830
Only index persons	18272	10791	7481
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.22
Only index persons	0.35	0.40	0.29
Median age at first event (years)
Whole population	45.48	49.99	39.01
Only index persons	45.16	49.69	38.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3298	2234	1064
Unadjusted period prevalence (%)	0.69	0.79	0.49
Median age at first event (years)	51.91	52.06	51.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3393: Matched controls
33930

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02AX02

ATC

tramadol; systemic, rectal

3.8

320.0

1767

7544

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

9.1

319.7

415

510

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

22.4

307.7

419

212

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

75.8

307.7

304

M54.4

ICD-10 Finland

Lumbago with sciatica

7.2

307.7

895

1611

N03AX16

ATC

[U] pregabalin

5.6

307.7

1071

2599

N03AX12

ATC

[U] gabapentin; oral

7.5

307.7

837

1426

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

227.2

307.7

1260

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

26.5

307.7

618

283

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

16.6

307.7

385

260

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

29.6

307.7

663

276

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

103.1

307.7

176

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

91.5

307.7

382

M79.6

ICD-10 Finland

Pain in limb

3.9

307.7

2097

9863

M48.0

ICD-10 Finland

Spinal stenosis

43.2

307.7

458

122

M54.5

ICD-10 Finland

Low back pain

4.1

307.7

1564

5808

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

404.6

307.7

2142

143

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.0

281.5

558

1081

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

24.0

273.2

197

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

119.8

271.5

138

M70.6

ICD-10 Finland

Trochanteric bursitis

4.7

266.1

733

1882

M25.5

ICD-10 Finland

Pain in joint

3.4

262.5

1624

7228

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

20.9

246.5

188

M01AH05

ATC

etoricoxib; oral

3.7

236.0

2583

15791

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.2

234.9

545

1208

M47.82

ICD-10 Finland

Other spondylosis, cervical region

18.6

230.0

185

105

N02BF01

ATC

gabapentin; oral

5.4

225.8

492

1031

N06AX21

ATC

duloxetine; oral

4.6

217.9

591

1485

M47.9

ICD-10 Finland

Spondylosis, unspecified

42.2

209.5

126

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

14.0

209.5

196

148

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

204.3

1759

9106

M76.0

ICD-10 Finland

Gluteal tendinitis

12.9

203.4

200

164

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

9.8

203.1

243

266

N02AJ06

ATC

codeine and paracetamol; systemic

2.9

201.4

1770

9243

M54.1

ICD-10 Finland

Radiculopathy

13.9

200.0

188

143

M54.3

ICD-10 Finland

Sciatica

8.7

194.8

256

316

M43.1

ICD-10 Finland

Spondylolisthesis

21.9

189.4

141

L03

ICPC

Low back symptom/complaint

2.9

171.7

1150

5107

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

9.9

168.5

198

211

M03BX02

ATC

tizanidine; oral

2.8

165.8

2381

15411

M03BC01

ATC

orphenadrine (citrate); systemic

3.0

162.3

936

3814

L13

ICPC

Hip symptom/complaint

3.1

157.4

839

3264

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

153.2

1039

4601

M01AB05

ATC

diclofenac; systemic, rectal

2.7

148.4

2466

16712

R52.2

ICD-10 Finland

Other chronic pain

7.3

148.3

224

324

M76.6

ICD-10 Finland

Achilles tendinitis

5.7

141.1

278

526

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

137.8

1467

8004

M02AA07

ATC

piroxicam; topical

2.5

133.1

1329

7018

A02BC05

ATC

esomeprazole; systemic

2.4

131.0

1537

8706

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

18.9

130.1

103

M54.2

ICD-10 Finland

Cervicalgia

4.7

129.5

322

744

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

15.3

129.3

114

M01AC06

ATC

meloxicam; systemic, rectal

2.4

128.0

1357

7333

L86

ICPC

Back syndrome with radiating pain

5.6

125.5

247

466

L17

ICPC

Foot/toe symptom/complaint

2.4

122.5

1219

6377

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

119.3

814

3558

M54.6

ICD-10 Finland

Pain in thoracic spine

4.4

118.9

318

777

M79.1

ICD-10 Finland

Myalgia

2.9

116.8

677

2717

N02BF02

ATC

pregabalin; oral

4.5

116.5

302

720

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.5

116.2

451

1431

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

112.1

107

M50.3

ICD-10 Finland

Other cervical disc degeneration

17.2

111.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.2

110.8

500

1739

R52.9

ICD-10 Finland

Pain, unspecified

3.3

110.2

463

1542

M01AH01

ATC

celecoxib; oral

2.8

110.2

655

2657

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

34.0

110.0

M01AE02

ATC

naproxen; oral, rectal

2.2

107.6

2098

14272

R51.80

ICD-10 Finland

Headache

2.8

106.8

665

2760

A02BC02

ATC

pantoprazole; systemic

2.3

105.8

2401

17318

N06AA09

ATC

amitriptyline; systemic

3.8

105.6

351

1003

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

105.0

987

4977

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

20.7

104.0

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

104.0

1024

5265

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

102.8

436

1458

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

29.2

99.0

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.4

98.0

262

638

M54.8

ICD-10 Finland

Other dorsalgia

5.3

97.5

203

402

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

96.9

953

4875

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

50.8

95.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.9

95.0

508

1937

H02AB06

ATC

prednisolone; systemic

2.1

93.8

1649

10570

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

38.6

92.7

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

5.2

92.1

194

388

M79.7

ICD-10 Finland

Fibromyalgia

5.7

91.8

176

323

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

91.3

757

3580

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

459.8

90.7

N02BE01

ATC

paracetamol; systemic, rectal

3.3

90.3

3105

25900

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

12.3

90.2

A01

ICPC

Pain general/multiple sites

3.2

89.8

403

1389

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.0

88.3

442

1621

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.5

88.3

148

238

X58

ICD-10 Finland

Exposure to other specified factors

2.6

88.2

627

2757

L16

ICPC

Ankle symptom/complaint

2.7

87.9

539

2203

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

87.2

953

5061

M45

ICD-10 Finland

Ankylosing spondylitis

34.9

87.0

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

36.6

86.5

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.7

85.6

542

2250

S18

ICPC

Laceration/cut

2.0

85.5

1607

10444

M70.7

ICD-10 Finland

Other bursitis of hip

6.2

85.1

148

247

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

84.2

830

4215

M01AX17

ATC

nimesulide; oral

2.3

83.3

786

3917

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

82.5

692

3275

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.4

82.3

121

169

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

10.1

81.9

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

81.5

969

5298

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

33.0

80.9

L08

ICPC

Shoulder symptom/complaint

2.2

80.7

863

4521

L15

ICPC

Knee symptom/complaint

2.1

80.5

970

5328

A02BC03

ATC

lansoprazole; oral

2.2

79.8

924

4994

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

79.3

1198

7151

R03AC02

ATC

salbutamol; inhalant

2.0

79.3

1946

13742

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

78.9

281

837

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

9.4

78.6

102

R5599

NOMESCO Finland

Other rehabilitation service

6.1

76.7

135

228

M01AH02

ATC

rofecoxib; oral

2.9

76.6

411

1561

R06.0

ICD-10 Finland

Dyspnoea

2.1

76.2

900

4888

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

8.0

75.8

104

134

M77.4

ICD-10 Finland

Metatarsalgia

3.2

75.5

318

1052

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.8

75.4

416

1603

J01FA10

ATC

azithromycin; systemic

2.0

75.2

2110

15473

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.9

74.3

385

1434

L14

ICPC

Leg/thigh symptom/complaint

3.0

74.2

352

1248

R4110

NOMESCO Finland

Physiotherapy

2.1

74.2

986

5592

R52.1

ICD-10 Finland

Chronic intractable pain

20.0

73.9

Z3226

NOMESCO Finland

Physiotherapist

2.3

73.2

637

3049

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

73.2

G44.2

ICD-10 Finland

Tension-type headache

2.5

73.0

525

2306

M77.1

ICD-10 Finland

Lateral epicondylitis

2.9

72.0

373

1388

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.4

71.5

271

839

A02BC01

ATC

omeprazole; systemic

2.1

71.1

891

4932

L28

ICPC

Limited function/disability (L)

2.4

70.8

587

2748

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

8.6

70.4

109

M35.7

ICD-10 Finland

Hypermobility syndrome

9.2

70.3

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

70.1

900

5022

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

70.1

977

5618

L29

ICPC

Musculoskeletal sympt/complt other

2.9

70.1

373

1408

J01AA02

ATC

doxycycline; systemic

2.1

69.6

2645

21247

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

68.3

520

2340

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

66.3

1914

13912

M43.0

ICD-10 Finland

Spondylolysis

29.7

66.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.1

65.9

289

977

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

65.8

1033

6170

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

333.5

65.7

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.6

64.7

415

1721

XA402

NOMESCO Finland

ENMG

6.7

64.2

103

158

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.4

63.5

236

721

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

63.2

1489

10113

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

63.1

481

2162

ZXA05

NOMESCO Finland

Left side

2.1

62.8

784

4307

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.3

62.4

251

805

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

217.4

62.3

N06AX11

ATC

mirtazapine; oral

1.9

62.3

1168

7374

J02AC01

ATC

fluconazole; systemic

1.8

62.2

1459

9881

R01AD09

ATC

mometasone; nasal

1.8

62.0

1635

11471

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

61.9

272

920

N06AX16

ATC

venlafaxine; oral

2.3

61.8

541

2582

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

61.7

299

1070

NE1BG, ,

SPAT

5.1

61.2

132

269

R42

ICD-10 Finland

Dizziness and giddiness

2.1

61.1

735

3978

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

6.7

60.9

151

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.6

60.7

379

1549

M54

ICD-10 Finland

Dorsalgia

2.4

59.9

446

1981

R4110, ,

SPAT

2.4

59.8

475

2171

ZXA00

NOMESCO Finland

Right side

2.0

59.2

822

4679

NA3BG, ,

SPAT

3.9

59.1

177

467

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

58.9

382

1589

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

58.8

401

1709

M01AB55

ATC

diclofenac, combinations; oral

3.4

58.1

215

654

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

57.8

654

3451

UJF32

NOMESCO Finland

Coloscopy

2.0

57.6

800

4549

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.0

57.5

167

431

R20.2

ICD-10 Finland

Paraesthesia of skin

2.9

57.1

279

1002

M01AX05

ATC

glucosamine; oral

2.2

55.7

554

2778

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

55.4

287

1064

J01DB01

ATC

cefalexin; oral

2.1

55.3

2811

23741

N02AJ13

ATC

tramadol and paracetamol; systemic

6.2

55.0

154

L01

ICPC

Neck symptom/complaint

2.1

54.7

575

2945

M02AA10

ATC

ketoprofen; topical

2.2

54.6

541

2707

WX320

NOMESCO Finland

Spinalanesthesy

1.9

54.3

835

4901

R03DC03

ATC

montelukast; oral

2.1

54.3

616

3248

R06AE07

ATC

cetirizine; oral

1.7

53.1

1548

11016

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.1

53.0

235

798

M01AH03

ATC

valdecoxib; oral

3.2

52.2

212

683

R53

ICD-10 Finland

Malaise and fatigue

1.9

52.2

862

5172

L12

ICPC

Hand/finger symptom/complaint

2.0

52.1

637

3447

B01AB05

ATC

enoxaparin; parenteral

1.8

51.9

998

6278

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.7

51.7

300

1179

J01FA06

ATC

roxithromycin; oral

1.8

51.4

1304

8897

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

51.1

785

4594

G54.0

ICD-10 Finland

Brachial plexus disorders

5.4

50.6

101

192

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

50.3

431

2028

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

49.9

653

3614

R05

ICPC

Cough

1.9

49.9

869

5291

R01AD58

ATC

fluticasone, combinations; nasal

1.8

49.8

956

5997

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

49.8

326

1359

SPAT1153

SPAT

Removal of sutures

1.8

49.3

933

5827

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

7.5

49.2

J01MA02

ATC

ciprofloxacin; systemic

1.8

49.0

1188

7975

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

48.9

376

1687

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

7.6

48.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

48.6

286

1131

R07.3

ICD-10 Finland

Other chest pain

2.5

48.5

347

1507

R01AD08

ATC

fluticasone; nasal

1.8

48.4

1021

6581

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

48.2

1391

9791

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

48.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.5

47.5

168

496

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

5.6

47.2

164

N02AA05

ATC

oxycodone; systemic

2.1

46.9

500

2563

M01AX01

ATC

nabumetone; oral

3.8

46.9

145

391

N04BC05

ATC

pramipexole; oral

2.8

46.8

248

929

J01DA01

ATC

[U] cefalexin

1.7

46.4

2010

15694

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.0

46.2

101

208

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

46.2

336

1469

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

46.2

520

2720

K30

ICD-10 Finland

Functional dyspepsia

2.2

46.1

414

1982

AA1AD

NOMESCO Finland

CT of head and brain

1.8

45.9

824

5045

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

45.9

218

769

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

45.9

1025

6697

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.1

45.6

126

313

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

8.0

45.6

R06AX27

ATC

desloratadine; oral

1.7

45.5

1071

7097

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.3

45.5

177

555

L02

ICPC

Back symptom/complaint

2.3

45.4

366

1675

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

14.3

45.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

45.0

1783

13556

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.5

44.9

110

249

A02BA02

ATC

ranitidine; systemic

2.0

44.9

554

2994

J01FF01

ATC

clindamycin; systemic

1.8

44.3

874

5499

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

5.3

44.0

175

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

43.9

158

472

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

97.4

43.9

N05BA04

ATC

oxazepam; oral

1.8

43.7

859

5393

Z3231

NOMESCO Finland

Registered nurse

1.8

43.7

859

5394

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

43.7

268

1081

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

43.5

2474

20596

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

43.5

315

1374

H02AB07

ATC

prednisone; oral

2.1

43.4

444

2237

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

43.3

356

1641

S80.0

ICD-10 Finland

Contusion of knee

2.5

43.3

304

1307

M76.7

ICD-10 Finland

Peroneal tendinitis

8.3

43.2

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

43.1

3092

27692

K07.60

ICD-10 Finland

Snapping jaw

2.9

42.6

211

761

Z71.8

ICD-10 Finland

Other specified counselling

1.7

42.3

1170

8067

R02

ICPC

Shortness of breath/dyspnoea

2.2

42.2

418

2078

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.8

42.2

132

359

R60.0

ICD-10 Finland

Localized oedema

2.2

42.1

396

1929

D01

ICPC

Abdominal pain/cramps general

2.1

42.0

448

2291

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

42.0

1099

7464

M89.0

ICD-10 Finland

Algoneurodystrophy

8.7

41.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

41.6

443

2265

M23.8

ICD-10 Finland

Other internal derangements of knee

3.3

41.5

165

524

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

41.4

438

2232

Z01.2

ICD-10 Finland

Dental examination

1.6

41.4

1626

12239

Z50.1

ICD-10 Finland

Other physical therapy

3.1

41.4

178

593

N01

ICPC

Headache

2.1

41.2

421

2118

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

41.1

795

4956

L18

ICPC

Muscle pain

3.2

41.0

169

549

M24.2

ICD-10 Finland

Disorder of ligament

5.9

41.0

128

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.9

41.0

190

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

41.0

210

772

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

40.6

1553

11595

N05CF01

ATC

zopiclone; oral

1.7

40.6

963

6358

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

40.5

255

1040

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

40.5

582

3305

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

40.4

1175

8187

S83.2

ICD-10 Finland

Tear of meniscus, current

2.5

40.4

264

1097

H02AB04

ATC

methylprednisolone; systemic

2.0

40.4

463

2431

NH1BG, ,

SPAT

4.4

40.1

103

242

NH3BG

NOMESCO Finland

MRI of foot

7.9

40.0

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

40.0

2422

20229

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

39.9

231

904

G47.3

ICD-10 Finland

Sleep apnoea

1.8

39.9

732

4488

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

39.5

246

998

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.9

39.5

198

719

M01AC01

ATC

piroxicam; systemic, rectal

2.1

39.4

398

1992

9211

FHL

Exploration or removal of diskusprolapse

391.9

39.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

38.9

1851

14512

N03AE01

ATC

clonazepam; systemic

2.9

38.9

189

675

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

38.9

449

2362

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.7

38.8

211

800

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.0

38.6

178

617

A03FA02

ATC

cisapride; oral, rectal

2.7

38.4

222

868

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

38.3

354

1709

R05

ICD-10 Finland

Cough

1.8

38.3

719

4432

N02AC04

ATC

dextropropoxyphene; oral

4.6

38.1

198

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

38.0

356

1728

SPAT1301

SPAT

No procedures

1.7

37.9

897

5899

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

37.7

894

5881

M19.8

ICD-10 Finland

Other specified arthrosis

3.2

37.7

155

503

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.7

37.6

192

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

37.5

311

1436

WX002

NOMESCO Finland

Sedation and analgesia

1.9

37.5

590

3444

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

13.6

37.4

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.2

37.3

151

485

J01FA09

ATC

clarithromycin; systemic

1.7

37.3

1025

7009

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

37.2

1015

6924

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

36.8

394

2013

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

36.8

1329

9716

R74

ICPC

Upper respiratory infection acute

1.6

36.8

1179

8373

ZXA10

NOMESCO Finland

Bilateral

1.9

36.7

555

3195

H02BX01

ATC

methylprednisolone, combinations; systemic

3.1

36.7

156

516

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

49.5

36.6

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.7

36.6

119

332

P01AB01

ATC

metronidazole; oral, rectal

1.6

36.5

1295

9422

J01CA04

ATC

amoxicillin; systemic

1.8

36.4

2758

24078

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

36.4

449

2415

L84

ICPC

Back syndrome without radiat pain

3.1

36.1

157

526

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

361.1

36.0

R03BA05

ATC

fluticasone; inhalant

1.8

35.9

596

3531

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.0

35.8

103

264

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.3

35.7

217

N05BA01

ATC

diazepam; systemic, rectal

2.1

35.4

392

2026

NA3AA, ,

SPAT

3.2

35.3

146

475

L04AX03

ATC

methotrexate; systemic

2.2

35.2

326

1574

M77.0

ICD-10 Finland

Medial epicondylitis

3.7

35.1

115

323

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.7

35.1

115

323

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

35.0

519

2967

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.5

34.8

124

368

M22.4

ICD-10 Finland

Chondromalacia patellae

3.3

34.7

131

403

P01BA02

ATC

hydroxychloroquine; oral

2.3

34.7

277

1258

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.3

34.7

ZXE00

NOMESCO Finland

One hour or less

1.6

34.5

1224

8873

C07AB07

ATC

bisoprolol; oral

1.6

34.5

1326

9794

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.8

34.5

182

679

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

34.4

415

2211

D06

ICPC

Abdominal pain localized other

2.2

34.4

319

1540

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

34.4

404

2134

N05CF02

ATC

zolpidem; oral

1.8

34.1

564

3334

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

34.0

269

1217

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

34.0

233

989

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

33.9

926

6293

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.1

33.8

145

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

33.8

220

911

R03BA02

ATC

budesonide; inhalant

1.8

33.6

580

3473

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

33.5

319

1557

R13

ICD-10 Finland

Dysphagia

2.5

33.3

219

911

R01AD12

ATC

fluticasone furoate; nasal

1.6

33.3

1090

7737

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

33.3

2267

18988

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.4

33.2

125

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

33.2

302

1447

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

33.1

268

1223

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.4

33.1

233

1000

R21

ICPC

Throat symptom/complaint

1.7

32.8

738

4760

R51

ICD-10 Finland

Headache

2.5

32.8

212

875

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

6.7

32.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

32.7

602

3671

SPAT1263

SPAT

Sampling

1.6

32.7

1247

9164

XQ800

NOMESCO Finland

Prick test

2.3

32.6

274

1270

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

32.5

422

2306

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.0

32.5

242

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.1

32.3

225

7266X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[ENTHESOPATHIA GENUS ALIA DEFINITA SEU NUD]

+∞

32.3

SPAT1216

SPAT

Assessment of functional ability

2.0

32.2

400

2151

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

32.2

269

1244

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

32.1

230

995

M25.2

ICD-10 Finland

Flail joint

6.0

32.1

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

32.1

224

958

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.7

32.1

101

276

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

6.4

32.0

ACC51

NOMESCO Finland

Release of median nerve

2.3

32.0

246

1098

N06AA10

ATC

nortriptyline; systemic

4.6

32.0

172

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

31.8

418

2291

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

31.8

554

3322

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

31.7

209

870

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.0

31.6

357

1857

E0000UV, ,

ATC

1.5

31.6

1352

10176

SFA20

NOMESCO Finland

Two-surface restoration

1.5

31.5

1963

16018

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

31.4

230

1005

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

31.4

399

2163

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

31.3

1166

8500

A02BC04

ATC

rabeprazole; oral

2.2

31.3

299

1459

N06AB04

ATC

citalopram; systemic

1.7

31.3

638

4000

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

31.0

351

1826

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.3

30.8

119

372

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

161.5

30.7

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.2

30.4

289

1408

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

30.4

281

1354

SPAT1310

SPAT

Counselling related to known health issue

1.6

30.4

920

6384

M41.9

ICD-10 Finland

Scoliosis, unspecified

9.1

30.4

UKC02

NOMESCO Finland

Cystoscopy

2.0

30.3

381

2057

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

30.2

166

632

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

29.9

311

1567

A11

ICPC

Chest pain NOS

2.2

29.9

260

1222

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

29.9

203

857

NA2BG, ,

SPAT

8.1

29.9

C07AA05

ATC

propranolol; systemic

1.7

29.8

657

4204

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

29.7

929

6488

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

29.7

984

6966

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.2

29.7

191

D07AC01

ATC

betamethasone; topical

1.6

29.6

1128

8243

R50.9

ICD-10 Finland

Fever, unspecified

1.8

29.6

474

2767

L90

ICPC

Osteoarthrosis of knee

2.4

29.5

213

924

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.4

29.5

203

862

SPAT1260

SPAT

Consultation of another employee

1.8

29.5

490

2892

M01AB08

ATC

etodolac; oral

2.4

29.5

219

963

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.1

29.5

128

429

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

29.4

284

1392

7267X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[ENTHESOPATHIA TARSI ALIA SEU NUD]

+∞

29.2

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

4.7

29.2

144

R03BA08

ATC

ciclesonide; inhalant

2.1

29.2

295

1471

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

29.1

184

751

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

29.0

253

1190

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

29.0

182

741

M75.2

ICD-10 Finland

Bicipital tendinitis

3.5

28.9

100

291

M20.2

ICD-10 Finland

Hallux rigidus

3.2

28.9

118

381

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

28.9

343

1813

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

28.7

338

1781

SPAT1229

SPAT

Assessment of need for aid

2.4

28.6

197

837

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

28.6

297

1496

Z2221

NOMESCO Finland

Medical doctor

1.6

28.5

861

5955

G04BD12

ATC

mirabegron; oral

2.0

28.5

329

1722

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.2

28.4

116

375

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.1

28.3

118

386

L09

ICPC

Arm symptom/complaint

2.5

28.3

177

719

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.1

28.2

117

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

4.1

28.2

190

M76.5

ICD-10 Finland

Patellar tendinitis

5.7

28.2

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

28.2

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

28.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

28.2

697

4589

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.8

28.1

148

551

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

28.1

195

831

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

28.1

177

721

NF1AA, ,

SPAT

2.5

28.1

182

752

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

28.1

404

2278

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

28.0

296

1500

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.9

27.9

132

464

M15

ICD-10 Finland

Polyarthrosis

2.7

27.9

157

605

N17

ICPC

Vertigo/dizziness

1.9

27.9

378

2090

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.9

27.8

214

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

100.9

27.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

27.6

360

1964

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.3

27.6

209

926

R35

ICD-10 Finland

Polyuria

2.5

27.6

187

789

R5110, ,

SPAT

2.2

27.4

255

1231

J01EA01

ATC

trimethoprim; systemic

1.6

27.4

777

5287

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.4

27.2

288

W19

ICD-10 Finland

Unspecified fall

2.0

27.2

299

1537

9476

FHL

Splitting of fascia or aponeurosis

7.4

27.1

1220

FHL

Arthroscopy

3.0

27.1

122

417

S22.3

ICD-10 Finland

Fracture of rib

2.3

27.1

213

959

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

27.1

165

662

NF1DA

NOMESCO Finland

X-ray of hips

4.2

27.0

170

J01DA09

ATC

[U] cefadroxil

1.6

27.0

825

5709

SFA10

NOMESCO Finland

One-surface restoration

1.5

27.0

1793

14614

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

27.0

291

1485

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

27.0

506

3088

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.0

26.9

124

430

R96

ICPC

Asthma

2.0

26.9

307

1600

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.3

26.8

163

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.3

26.7

C05AA08

ATC

fluocortolone; rectal, topical

1.8

26.7

406

2328

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

26.7

1350

10416

A04

ICPC

Weakness/tiredness general

1.8

26.6

482

2911

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

26.6

626

4061

R03BA01

ATC

beclometasone; inhalant

1.8

26.5

412

2377

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

9.2

26.5

N06AB10

ATC

escitalopram; oral

1.6

26.5

676

4478

R4120

NOMESCO Finland

Occupational therapy

2.3

26.4

214

976

SPAT1312

SPAT

General health counselling

1.5

26.4

940

6731

R11

ICD-10 Finland

Nausea and vomiting

2.1

26.4

275

1386

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.4

26.3

192

837

XF402

NOMESCO Finland

ECG with work load test

2.1

26.2

277

1403

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

26.2

217

999

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

26.0

26.1

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

26.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

26.0

135

499

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.0

26.0

113

379

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

26.0

1184

8930

L05

ICPC

Flank/axilla symptom/complaint

2.3

25.9

206

932

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

25.9

150

587

M03BX01

ATC

baclofen; systemic

4.2

25.9

163

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

25.9

701

4709

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

7.0

25.9

M76

ICD-10 Finland

Enthesopathies of lower limb, excluding foot

7.0

25.9

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.4

25.8

283

M75

ICD-10 Finland

Shoulder lesions

2.5

25.8

160

647

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

40.4

25.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

25.8

925

6629

M67.4

ICD-10 Finland

Ganglion

2.1

25.8

246

1199

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

25.7

362

2024

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.8

25.7

217

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

6.3

25.7

C10AA05

ATC

atorvastatin; oral

1.5

25.6

1138

8531

M76.3

ICD-10 Finland

Iliotibial band syndrome

7.8

25.5

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.9

25.5

116

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

25.5

430

2542

TAB00

NOMESCO Finland

Lumbar puncture

2.6

25.5

147

574

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

25.3

275

1407

SPAT1211

SPAT

Application of soft bandage

2.1

25.3

264

1331

R07.0

ICD-10 Finland

Pain in throat

2.1

25.3

251

1242

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.4

25.3

145

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.7

25.2

141

542

R00.2

ICD-10 Finland

Palpitations

2.0

25.2

271

1381

A01AB09

ATC

miconazole; local oral

2.1

25.1

247

1217

G04BD08

ATC

solifenacin; oral

2.4

25.1

184

804

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

25.1

562

3596

R03AC03

ATC

terbutaline; inhalant

1.8

25.1

429

2547

J45

ICD-10 Finland

Asthma

1.9

25.0

341

1886

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

25.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

25.0

142

550

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.4

25.0

174

743

R06AE09

ATC

levocetirizine; oral

1.7

25.0

483

2970

J20

ICD-10 Finland

Acute bronchitis

1.9

24.9

331

1815

M77.5

ICD-10 Finland

Other enthesopathy of foot

5.3

24.8

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.6

24.8

144

564

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

9.2

24.7

C03CA01

ATC

furosemide; systemic

1.6

24.7

672

4512

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

24.7

121

434

D02

ICPC

Abdominal pain epigastric

2.2

24.6

204

939

XKD00

NOMESCO Finland

Uroflowmetry

1.9

24.6

313

1692

L11

ICPC

Wrist symptom/complaint

1.9

24.6

321

1750

H57.1

ICD-10 Finland

Ocular pain

2.6

24.6

140

543

H93.1

ICD-10 Finland

Tinnitus

2.2

24.5

228

1100

K02.1

ICD-10 Finland

Caries of dentine

1.5

24.5

1930

16129

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

24.4

949

6904

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

24.4

227

1095

Z00.0

ICD-10 Finland

General medical examination

1.7

24.4

566

3653

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

24.3

274

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

24.3

1055

7853

R03AC13

ATC

formoterol; inhalant

2.5

24.3

156

642

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

24.2

168

716

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

24.2

167

710

J01MA12

ATC

levofloxacin; systemic

1.7

24.2

504

3161

H01

ICPC

Ear pain/earache

1.8

24.1

388

2260

S29

ICPC

Skin symptom/complaint other

1.6

24.1

624

4139

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.8

24.0

125

463

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

24.0

118

424

P06

ICPC

Sleep disturbance

1.8

23.9

415

2473

C10AA07

ATC

rosuvastatin; oral

1.5

23.9

988

7277

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

23.8

243

1214

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.8

23.8

115

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

67.9

23.8

NH1AA, ,

SPAT

2.7

23.7

133

512

L20

ICPC

Joint symptom/complaint NOS

2.7

23.7

130

495

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

23.6

154

638

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

23.5

757

5278

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.0

23.5

106

363

GD1AA, ,

SPAT

1.6

23.5

581

3807

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.6

23.5

138

544

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

23.5

446

2726

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.8

23.5

189

L10

ICPC

Elbow symptom/complaint

2.2

23.4

200

932

J01DA06

ATC

[U] cefuroxime

1.7

23.4

438

2666

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

23.3

567

3700

S70.0

ICD-10 Finland

Contusion of hip

2.8

23.2

120

443

TAB20

NOMESCO Finland

Epidural puncture

9.7

23.2

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

23.1

267

1395

R09

ICPC

Sinus symptom/complaint

2.0

23.1

272

1432

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.0

618

4131

NHA30

NOMESCO Finland

Exploration of joint of ankle or foot, arthroscopic

6.9

22.9

OAA65, ,

SPAT

1.6

22.9

686

4705

G50.1

ICD-10 Finland

Atypical facial pain

4.1

22.8

157

F29

ICPC

Eye symptom/complaint other

1.8

22.6

340

1938

WX402

NOMESCO Finland

General anaesthesia

1.6

22.6

694

4782

NH3AA, ,

SPAT

2.1

22.6

229

1142

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.7

22.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

22.6

376

2212

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

3.7

22.5

199

D11

ICPC

Diarrhoea

1.8

22.5

388

2304

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

20.8

22.5

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

22.5

174

778

D19

ICPC

Teeth/gum symptom/complaint

1.5

22.4

1024

7674

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.5

22.4

125

U02

ICPC

Urinary frequency/urgency

1.7

22.3

447

2770

A29

ICPC

General symptom/complaint other

1.8

22.3

379

2243

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.5

22.3

215

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

22.2

775

5493

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.5

22.2

225

EB1VA, ,

NOMESCO Finland

1.6

22.2

578

3831

C01CA24

ATC

epinephrine; parenteral

2.1

22.2

214

1047

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

22.2

274

1466

ZXD20

NOMESCO Finland

Day surgery

1.8

22.1

389

2323

M53.2

ICD-10 Finland

Spinal instabilities

52.4

22.1

M09AX01

ATC

hyaluronic acid; parenteral

2.7

22.1

120

455

R12

ICD-10 Finland

Heartburn

2.0

22.0

270

1440

C09CA06

ATC

candesartan; oral

1.5

21.9

740

5204

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.2

21.9

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

21.9

226

1134

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

21.9

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

21.9

L04

ICPC

Chest symptom/complaint

2.2

21.8

199

952

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

21.8

665

4572

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

21.8

910

6693

SPAT1106

SPAT

Acupuncture

7.2

21.6

M02AA15

ATC

diclofenac; topical

2.1

21.6

215

1065

N03AX09

ATC

lamotrigine; oral

2.3

21.5

158

691

C08CA01

ATC

amlodipine; oral

1.5

21.4

999

7507

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.8

21.4

109

400

J46

ICD-10 Finland

Status asthmaticus

3.1

21.3

287

RF210, ,

NOMESCO Finland

3.1

21.3

282

M19.2

ICD-10 Finland

Other secondary arthrosis

4.7

21.2

106

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

21.2

397

2412

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.5

21.1

132

536

N05AH04

ATC

quetiapine; oral

1.6

21.1

520

3397

NA1BG, ,

SPAT

3.8

21.1

171

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

8.5

21.0

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

21.0

316

1802

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

20.9

167

757

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.9

20.9

333

UJD02

NOMESCO Finland

Gastroscopy

2.5

20.8

135

558

R03BB04

ATC

tiotropium bromide; inhalant

2.0

20.8

233

1204

G04CA02

ATC

tamsulosin; oral

1.7

20.8

427

2661

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

20.7

302

NG1BG, ,

SPAT

2.2

20.7

169

774

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

20.7

496

3218

R06AX22

ATC

ebastine; oral

1.6

20.6

556

3710

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.2

20.6

251

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

20.6

270

1472

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

211.2

20.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

20.5

354

2101

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.4

20.5

212

J05AB11

ATC

valaciclovir; oral

1.7

20.4

449

2848

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

6.7

20.4

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

4.3

20.4

122

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.9

20.4

343

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

20.4

314

1803

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.8

20.3

355

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.1

20.2

197

967

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

20.2

221

1132

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.5

20.2

195

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

20.2

686

4822

A97

ICPC

No disease

1.6

20.1

603

4121

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

20.1

175

823

SPAT1283

SPAT

Restricted health certificate

1.6

20.0

553

3709

N03AF01

ATC

carbamazepine; oral, rectal

2.4

19.9

134

564

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

19.9

313

1808

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

5.2

19.8

7267B

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS TIBIALIS ANTERIORIS ET POSTERIORIS]

+∞

19.8

NHE15

NOMESCO Finland

Suture or reinsertion of ligament of ankle

5.5

19.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

19.8

327

1917

K08.80

ICD-10 Finland

Toothache NOS

1.8

19.6

301

1725

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

4.8

19.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

19.6

367

2229

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

6.6

19.6

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

19.5

214

1097

R52.0

ICD-10 Finland

Acute pain

2.6

19.5

110

425

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

19.5

1133

8833

D07AD01

ATC

clobetasol; topical

1.6

19.5

506

3342

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

4.0

19.5

135

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

2.6

19.5

109

420

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.7

19.4

167

L87

ICPC

Bursitis/tendinitis/synovitis NOS

3.8

19.4

158

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.9

19.3

309

SPAT1240

SPAT

Therapeutic discussion

1.8

19.3

319

1870

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

19.3

120

487

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

19.2

146

648

N39.3

ICD-10 Finland

Stress incontinence

2.0

19.2

230

1216

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

19.2

132

561

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.3

19.1

222

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

7.2

19.1

M01AE52

ATC

naproxen and esomeprazole; oral

2.8

19.1

350

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.4

19.0

138

601

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

19.0

126

527

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

19.0

168

795

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

5.3

18.9

NG2AA

NOMESCO Finland

Patella X-ray examination

2.8

18.8

330

S06.0

ICD-10 Finland

Concussion

1.8

18.8

301

1748

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.1

18.8

D07AA02

ATC

hydrocortisone; topical

1.7

18.7

416

2644

NA3CG, ,

SPAT

4.6

18.7

D07AC13

ATC

mometasone; topical

1.5

18.7

852

6345

F01

ICPC

Eye pain

2.7

18.6

100

377

A06AD11

ATC

lactulose; oral

1.7

18.6

336

2020

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1028

4623

2.76

146.14

1.5

1.3

9.17

12.43

u/ml

0.83

399

1904

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1067

5046

2.63

135.59

1.5

1.3

30.18

30.24

iu/ml

0.00

319

1534

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2672

20606

2.40

93.91

5.8

3.9

10.60

11.36

mm/h

2.34

2558

19304

(3037522) Nuclear Ab [Titer] in Serum

794

3948

2.32

84.76

1.5

1.4

451.72

575.32

titre

1.17

174

872

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1058

5960

2.13

82.53

2.1

1.7

0.95

1.19

mg/l

2.02

787

4572

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1251

7574

2.03

79.72

2.5

2.0

187.51

227.36

u/l

0.57

1197

7170

(3006315) Basophils [#/volume] in Blood

1985

14300

1.94

74.08

7.2

6.4

0.04

e9/l

0.68

1761

12309

(3013115) Eosinophils [#/volume] in Blood

2034

14787

1.94

73.68

7.4

6.6

0.18

0.19

e9/l

0.44

1839

12935

(3001604) Monocytes [#/volume] in Blood

1981

14277

1.93

73.66

7.2

6.4

0.56

e9/l

0.34

1761

12291

(3019198) Lymphocytes [#/volume] in Blood

2015

14620

1.93

73.23

7.2

6.4

1.94

1.93

e9/l

0.26

1825

12903

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1844

13119

1.89

69.79

7.0

7.1

1.22

1.21

mmol/l

1.50

1622

11327

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2646

21320

2.10

68.09

8.8

8.0

76.04

78.76

u/l

2.63

2532

20286

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

440

1873

2.55

64.97

2.6

2.4

19.76

22.28

au/ml

0.28

258

(3013650) Neutrophils [#/volume] in Blood by Automated count

2132

16150

1.86

63.43

9.2

10.3

3.90

3.99

e9/l

1.37

1890

13994

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

409

1728

2.55

61.17

1.4

1.3

52.31

56.26

au/ml

0.12

130

(3022096) Basophils/Leukocytes in Blood

1813

13224

1.80

59.39

7.5

6.6

0.71

0.69

0.50

1706

12434

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1647

11680

1.80

59.33

6.1

6.5

1.22

1.21

mmol/l

1.53

1531

10835

(3032080) INR in Blood by Coagulation assay

1616

11435

1.79

58.30

14.6

12.4

1.19

1.20

inr

0.40

1310

9435

(3006504) Eosinophils/Leukocytes in Blood

1806

13223

1.78

57.77

7.4

6.5

2.80

2.82

0.14

1695

12452

(3019069) Monocytes/Leukocytes in Blood

1807

13246

1.78

57.44

7.5

6.6

8.66

8.73

0.55

1700

12478

(3018010) Neutrophils/Leukocytes in Blood

1820

13388

1.78

56.98

7.3

6.4

56.12

56.96

2.51

1739

12844

(3002030) Lymphocytes/Leukocytes in Blood

1845

13648

1.77

56.43

7.4

6.5

29.29

28.37

3.27

1756

13005

(3031040) Bacteria [#/volume] in Urine by Automated count

2265

17805

1.82

56.12

5.6

4.0

3181.50

2082.22

e6/l

0.22

245

(40768797) Stomach Pathology biopsy report

678

3668

2.06

55.87

1.3

1.2

—

(3008898) HLA-B27 [Presence]

249

852

3.07

55.46

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1082

6909

1.83

54.03

2.5

332.05

334.17

umol/l

0.28

951

6259

(3018418) pH of Serum or Plasma

1182

7773

1.80

53.40

4.1

4.3

7.40

0.52

889

5449

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1070

6889

1.81

51.50

1.4

1.3

0.76

1.92

u/ml

7.95

288

1885

(3009261) Glucose [Presence] in Urine by Test strip

1935

14733

1.73

51.34

4.4

3.4

0.01

0.13

estimate

0.56

401

2877

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1226

8225

1.77

51.24

2.9

2.6

61.48

62.50

u/l

0.08

1138

7639

(3048689) Calprotectin [Mass/mass] in Stool

670

3718

2.00

50.96

2.3

2.5

99.22

122.43

ug/g

1.30

544

2992

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1596

11588

1.71

49.83

2.3

2.0

98.93

97.08

pmol/l

0.77

794

6031

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1355

9426

1.73

49.31

4.0

3.1

29.80

66.51

ng/l

1.73

828

5875

(3035350) Ketones [Presence] in Urine by Test strip

1913

14626

1.71

48.98

4.4

3.4

13.47

5.59

estimate

0.59

420

3054

(3007164) IgA [Mass/volume] in Serum or Plasma

961

6074

1.81

48.68

1.5

2.20

2.32

g/l

1.67

567

3889

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3181

28600

2.80

48.52

19.5

13.1

20.13

23.67

mg/l

8.41

2689

22874

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1871

14243

1.70

48.47

6.1

6.8

10.30

11.31

umol/l

5.72

1777

13592

(3021601) Nitrite [Presence] in Urine by Test strip

1892

14478

1.69

47.77

4.4

3.4

0.00

estimate

0.80

414

2990

(3030467) Casts [#/volume] in Urine by Automated count

1093

7218

1.76

47.44

3.8

3.0

0.29

0.42

e6/l

2.00

830

5090

(3024561) Albumin [Mass/volume] in Serum or Plasma

1616

11875

1.69

47.43

5.3

5.2

36.64

36.03

g/l

4.86

1516

11183

(3013826) Glucose [Moles/volume] in Serum or Plasma

2021

15756

1.70

47.42

5.1

4.7

6.44

6.65

mmol/l

4.94

1939

14810

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1752

13162

1.68

47.20

2.9

2.4

76.35

76.56

nmol/l

0.13

1606

12119

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2699

22858

1.88

47.16

5.3

4.4

14.59

14.63

pmol/l

0.33

2537

21191

(3015171) Extractable nuclear Ab [Units/volume] in Serum

269

1055

2.68

46.41

1.2

0.28

1.21

u/ml

1.41

(3002582) Erythrocytes [#/volume] in Urine

1222

8373

1.72

46.21

3.9

3.1

120.40

92.19

e6/l

0.16

959

6193

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1859

14257

1.67

45.66

3.6

3.0

102.28

110.42

ug/l

1.03

1756

13463

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1706

12813

1.67

45.29

2.9

2.6

—

estimate

—

(3015736) pH of Urine

1580

11663

1.66

44.63

3.8

3.1

6.21

6.18

0.44

885

6600

(3018095) Leukocytes [#/volume] in Urine

1385

9934

1.67

43.35

4.7

3.6

75.94

109.27

e6/l

1.05

1009

6666

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1012

6720

1.72

42.05

3.1

3.0

896.75

1261.88

ng/l

3.09

847

5720

(3023420) DNA double strand Ab [Units/volume] in Serum

276

1150

2.52

42.00

1.7

1.9

5.76

6.72

iu/ml

0.28

268

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1016

6816

1.70

40.34

2.5

2.2

2.70

2.77

mg/l

0.46

884

5889

(3021960) Folate [Moles/volume] in Serum or Plasma

1053

7144

1.69

40.02

1.8

1.6

20.26

20.40

nmol/l

0.13

919

6118

(3000850) Epithelial cells [#/volume] in Urine

867

5596

1.74

39.48

3.0

2.6

5.57

6.83

e6/l

2.09

806

5079

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

718

4453

1.78

37.32

3.4

2.7

1.09

1.22

e6/l

0.31

376

2214

(3044889) 12 lead EKG panel

2341

19558

1.64

36.71

4.3

3.5

28203.20

8886.57

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

471

2582

1.96

36.10

2.3

362.00

386.05

nmol/l

2.00

439

2412

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3003

26961

1.99

35.70

6.6

5.2

1.76

1.87

mu/l

5.44

2853

25171

(3044640) Blood type and Crossmatch panel - Blood

1218

8867

1.58

33.46

2.5

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3149

28942

2.22

32.38

20.7

15.1

139.72

139.73

mmol/l

0.12

3117

28336

(3021589) Normoblasts [#/volume] in Blood

1631

12756

1.54

32.10

12.7

10.6

0.00

e9/l

0.84

1346

10354

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

653

4119

1.72

31.36

3.5

2.8

4.33

3.02

e6/l

1.40

313

1874

(3023103) Potassium [Moles/volume] in Serum or Plasma

3150

29019

2.19

31.13

21.0

15.2

3.96

3.95

mmol/l

0.75

3115

28338

(3005322) IgE [Units/volume] in Serum or Plasma

354

1847

2.02

31.03

1.4

1.3

118.82

223.00

u/ml

4.13

337

1716

(3026782) Osmolality of Urine

741

4855

1.67

30.84

3.1

2.7

516.22

527.61

mosm/kgh2o

0.72

660

4249

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2334

19845

1.56

30.55

3.6

3.1

—

(3045414) Leukocytes [Presence] in Urine

418

2328

1.91

30.27

2.1

2.0

0.00

0.02

estimate

1.22

511

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

720

4731

1.66

29.47

4.8

3.3

290.71

449.93

ng/l

0.69

504

3415

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

950

6689

1.58

29.29

2.4

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1268

9525

1.53

29.23

3.1

3.7

2.36

mmol/l

0.06

1151

8779

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

359

1927

1.97

28.95

3.3

4.2

74.08

88.40

ng/l

4.02

321

1671

(3033658) Prothrombin time (PT) actual/Normal

987

7028

1.57

28.91

4.8

4.0

92.44

92.41

0.01

971

6898

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

454

2642

1.83

28.54

2.8

2.3

29.61

58.75

u/l

0.97

384

2266

(3014051) Protein [Presence] in Urine by Test strip

1116

8221

1.53

27.84

3.2

2.7

0.06

0.04

0.17

171

(40758558) Short blood count panel - Blood

1142

8457

1.53

27.78

6.2

6.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

502

3040

1.76

27.55

1.9

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1417

11024

1.49

26.96

4.2

3.3

1.46

0.29

estimate

0.37

347

2451

(3022145) Colonoscopy Study observation

513

3148

1.74

26.83

1.3

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

344

1876

1.93

26.40

2.4

2.7

66.44

66.57

g/l

0.12

319

1742

(40760892) CBC W Ordered Manual Differential panel - Blood

930

6653

1.55

26.21

4.5

4.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

751

5122

1.60

26.04

2.6

3.0

2.44

2.45

mmol/l

1.10

654

4632

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

192

843

2.35

25.91

1.5

1.8

0.24

0.23

g/l

0.05

185

805

(3022948) Iron [Moles/volume] in Serum or Plasma

670

4457

1.63

25.71

2.5

13.49

13.51

umol/l

0.02

630

4177

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

196

877

2.31

25.32

1.5

1.8

1.24

1.19

g/l

1.40

189

840

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

854

6041

1.55

25.14

1.7

1.5

—

(3023368) Bacteria identified in Blood by Culture

939

6816

1.52

24.44

4.6

4.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2944

26911

1.71

24.26

6.6

5.6

38.69

38.64

mmol/mol

0.13

2797

25410

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2386

20796

1.50

24.24

3.8

3.1

44.59

44.03

u/l

0.13

2255

19728

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3025

27873

1.79

24.07

17.4

12.9

84.52

84.47

ml/min/173m2

0.05

2864

25472

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

182

807

2.33

24.01

1.3

1.2

4.34

3.14

u/ml

0.16

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

182

809

2.32

23.87

1.3

3.66

8.91

u/ml

1.28

124

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

264

3.36

23.63

1.2

—

(40768804) Tissue Pathology biopsy report

1495

11964

1.45

23.52

2.2

2.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

167

720

2.39

23.48

1.4

292.69

290.02

ug/g

0.05

416

(3004789) Transferrin [Mass/volume] in Serum or Plasma

619

4126

1.61

23.32

2.5

2.40

2.35

g/l

1.68

570

3825

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

190

869

2.26

23.30

1.3

1.2

49.49

41.02

u/ml

—

(3026008) Bacteria identified in Urine by Culture

1038

7762

1.49

23.14

3.5

2.8

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

234

3.48

23.01

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1025

7678

1.48

22.53

4.6

3.5

0.00

estimate

1.98

400

2790

(40759836) Histone Ab [Presence] in Serum by Immunoblot

228

3.48

22.47

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

215

1054

2.11

22.16

2.0

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

136

551

2.53

21.88

1.7

1.6

5975.71

13548.70

e6/l

2.53

100

378

(3042936) Bacteria identified in Isolate by Culture

549

3624

1.61

21.37

2.2

2.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

227

3.40

21.19

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

504

3267

1.64

21.10

2.6

2.8

5.37

8.13

umol/l

5.56

441

2855

(3018333) Ribosomal P Ab [Presence] in Serum

214

3.46

20.95

1.2

—

(3000494) Fungus identified in Specimen by Culture

521

3420

1.62

20.70

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

576

3879

1.58

20.55

1.8

1.7

1166.67

1128.15

nmol/l

0.48

444

2974

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

564

3785

1.59

20.41

2.6

22.43

23.19

0.76

533

3531

(3041096) Erythrocytes [Presence] in Urine by Automated

1073

8233

1.44

20.37

3.7

3.0

0.09

0.17

estimate

0.26

356

2353

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

220

3.37

20.09

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

220

3.37

20.09

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3238

30746

2.16

20.01

14.0

10.9

26.51

26.22

u/l

0.51

3171

29966

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

226

3.33

19.94

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

148

651

2.33

19.91

1.3

1.2

1.18

1.45

u/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

152

681

2.29

19.59

1.3

1.2

—

16.01

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

310

1795

1.80

19.53

1.8

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3245

30872

2.17

19.39

23.5

16.7

74.76

74.06

umol/l

0.78

3222

30522

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

150

674

2.28

19.21

2.0

2.2

0.00

g/l

-0.00

131

595

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

112

4.33

18.97

1.2

1.7

4.60

5.87

u/l

1.84

(3019150) Specific gravity of Urine by Refractometry

826

6102

1.47

18.89

4.3

3.5

1.02

kg/l

0.33

545

3924

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1239

9855

1.41

18.88

3.5

3.3

29.61

36.92

u/l

2.62

1173

9348

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

224

1188

1.95

18.56

2.1

40.34

39.32

u/l

0.34

208

1085

(3017732) Neutrophils [#/volume] in Blood

513

3442

1.58

18.44

2.5

3.5

4.17

4.30

e9/l

0.25

463

3052

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2967

27555

1.61

18.43

5.5

4.6

5.86

5.83

mmol/l

0.54

2792

25578

(3003458) Phosphate [Moles/volume] in Serum or Plasma

509

3413

1.58

18.34

5.4

6.6

1.02

1.04

mmol/l

1.04

467

3185

(3009508) Creatinine [Moles/volume] in Urine

1171

9295

1.40

17.79

3.4

3.5

7.65

7.58

mmol/l

0.18

997

7950

(3005719) IgG [Mass/volume] in Serum or Plasma

353

2177

1.69

17.76

3.2

2.9

10.47

10.61

g/l

0.32

330

2029

(36660697) Celiac disease serology panel - Serum

382

2406

1.66

17.75

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

873

2.06

17.23

2.3

2.2

2.89

2.93

g/l

0.15

162

800

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

318

1924

1.72

17.15

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

733

2.15

17.15

1.2

3.59

4.51

0.66

126

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

144

668

2.21

17.10

1.2

44.06

38.54

u/ml

0.10

(3012095) Magnesium [Moles/volume] in Serum or Plasma

617

4389

1.50

16.83

3.6

3.7

0.81

0.82

mmol/l

0.48

586

4156

(3013139) Helicobacter pylori Ag [Presence] in Stool

312

1889

1.72

16.78

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

928

2.00

16.53

2.3

2.1

7.20

7.34

g/l

0.52

168

854

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

137

632

2.22

16.50

2.1

2.2

0.00

g/l

-0.00

130

594

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

180

925

2.00

16.34

2.3

2.1

3.55

3.77

g/l

1.83

168

855

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

183

947

1.99

16.29

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

180

927

1.99

16.24

2.3

2.1

4.14

4.27

g/l

1.53

169

854

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1483

12357

1.36

16.21

2.0

1.8

1.39

1.37

mmol/l

0.49

1254

10550

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

146

696

2.15

16.21

2.1

2.2

0.01

0.02

g/l

0.78

134

626

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

573

4046

1.50

16.14

2.0

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

807

2.06

16.03

2.1

9.68

10.37

g/l

1.53

149

728

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

437

2937

1.56

15.43

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

265

1577

1.74

15.14

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

675

2.12

15.11

1.1

—

(3025159) Blasts/Leukocytes in Blood

362

2345

1.61

14.95

4.5

4.8

0.12

0.38

0.69

585

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

159

811

2.01

14.76

2.1

2.3

0.49

0.94

g/l

1.44

143

698

(3025941) Bacteria identified in Stool by Culture

252

1490

1.75

14.73

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

139

679

2.09

14.51

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

284

1744

1.69

14.47

2.3

2.1

7.41

7.99

ug/l

0.11

233

1558

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2929

27413

1.50

14.40

4.6

4.0

1.31

1.27

mmol/l

2.25

2735

25589

(3002179) Metamyelocytes/Leukocytes in Blood

353

2295

1.60

14.34

4.2

4.4

0.56

0.67

0.53

674

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

413

2787

1.55

14.28

1.9

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3091

29288

1.62

14.23

6.2

5.2

2.77

2.82

mmol/l

2.76

2923

27599

(3021440) Promyelocytes/Leukocytes in Blood

355

2316

1.60

14.21

4.4

4.7

0.16

0.11

0.23

623

(3022621) pH of Urine by Test strip

330

2124

1.61

13.97

2.6

2.4

6.06

6.07

0.07

204

1356

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

136

3.49

13.86

1.3

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

365

2412

1.58

13.82

4.4

4.6

1.03

0.97

0.07

718

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

125

598

2.13

13.79

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

136

673

2.06

13.73

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2668

24605

1.39

13.65

22.8

16.7

13.52

13.50

0.27

2644

24259

(3027945) Reticulocytes/Erythrocytes in Blood

404

2741

1.54

13.60

2.3

2.9

1.76

0.01

370

2461

(3004616) Nuclear Ab [Presence] in Serum

343

2.49

13.41

1.6

1.3

—

(3044941) Cell count panel - Synovial fluid

411

2.35

13.37

1.6

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

307

1969

1.61

13.17

3.5

3.6

4.48

4.53

pmol/l

0.47

273

1791

(3035941) MCH [Entitic mass]

3304

32000

2.24

13.15

28.5

20.3

30.32

30.22

2.71

3288

31683

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3304

32000

2.24

13.15

28.5

20.3

90.95

90.72

2.45

3288

31683

(3007461) Platelets [#/volume] in Blood

3303

31991

2.22

13.07

28.6

20.4

258.97

256.69

e9/l

1.28

3273

31362

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3304

32005

2.23

13.06

29.0

20.7

40.61

41.04

0.91

3288

31667

(3026361) Erythrocytes [#/volume] in Blood

3304

32006

2.23

13.04

28.6

20.3

4.50

4.52

e12/l

1.33

3266

31284

(3010813) Leukocytes [#/volume] in Blood

3304

32014

2.22

12.89

28.6

20.4

6.65

6.60

e9/l

0.74

3269

31281

(3000963) Hemoglobin [Mass/volume] in Blood

3304

32015

2.22

12.88

28.7

20.5

135.65

135.68

g/l

0.04

3288

31704

(3012516) Albumin [Mass/volume] in Urine

1042

8448

1.34

12.84

3.5

30.19

46.62

mg/l

2.54

645

5297

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3056

28980

1.55

12.84

5.6

4.7

4.70

4.76

mmol/l

3.26

2902

27426

(3045424) Erythrocytes [Presence] in Urine

213

1255

1.74

12.61

2.2

2.0

0.03

0.01

estimate

0.23

400

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

767

1.94

12.49

2.4

2.2

11.53

11.81

mg/l

0.14

139

728

(3028026) IgM [Mass/volume] in Serum or Plasma

272

1719

1.63

12.38

1.8

1.9

1.27

1.41

g/l

0.80

252

1594

(3052851) Hemolysis interference index of Serum or Plasma

134

687

1.99

12.30

2.5

3.1

3.20

2.11

index

0.23

368

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3040

28836

1.52

12.30

5.5

4.6

1.47

1.49

mmol/l

3.11

2869

27136

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

159

870

1.87

12.04

1.5

0.01

0.43

iu/ml

1.17

144

(3020682) Albumin/Creatinine [Ratio] in Urine

1051

8598

1.32

11.99

4.0

4.3

4.54

8.53

mg/mmol

5.25

630

5339

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

151

814

1.89

11.97

2.2

2.3

330.29

810.19

ug/l

1.01

142

773

(40768443) Skin Pathology biopsy report

206

1224

1.73

11.85

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

310

2043

1.57

11.85

2.4

2.2

13.71

13.30

nmol/l

0.42

284

1901

(3018677) aPTT in Platelet poor plasma by Coagulation assay

532

3915

1.43

11.81

2.3

2.1

29.52

29.43

0.12

513

3808

(3021447) Carbon dioxide [Partial pressure] in Venous blood

356

2425

1.52

11.72

4.8

4.0

5.88

5.80

kpa

0.92

349

2359

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

710

5494

1.37

11.71

1.7

1.6

10580648.06

32592866.47

pmol/l

1.00

586

4679

(40761535) Cells panel - Urine sediment

262

1667

1.62

11.61

4.0

3.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

235

1456

1.66

11.57

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

213

2.75

11.50

1.1

1.3

0.79

1.72

u/ml

0.71

112

(3030981) Hyaline casts [#/volume] in Urine by Automated count

299

1969

1.57

11.46

2.2

2.4

0.62

0.47

e6/l

0.36

290

1866

(4094501) Cardiovascular stress test using bicycle ergometer

142

769

1.88

11.12

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

184

1079

1.75

11.10

1.6

1.7

4.89

13.89

u/ml

5.35

314

(3017143) Hepatitis C virus Ab [Presence] in Serum

493

3619

1.42

11.06

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

300

2020

1.53

10.41

2.7

2.9

71.00

70.16

e9/l

0.14

219

1474

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

199

1218

1.67

10.28

2.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

119

625

1.94

10.25

1.7

1.8

223.31

207.45

pmol/l

0.73

113

595

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

103

516

2.03

10.15

1.2

1.1

11.99

14.28

au/ml

0.18

158

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

314

2.32

10.04

1.2

1.3

0.17

0.24

nmol/l

0.59

247

(3024980) IgG subclass 4 [Mass/volume] in Serum

479

2.06

9.94

1.4

1.7

0.68

0.84

g/l

0.97

383

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

229

1465

1.60

9.94

1.8

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

129

706

1.86

9.82

3.1

3.2

38.46

62.94

mg/l

0.68

108

596

(3002032) Base excess in Venous blood by calculation

339

2370

1.48

9.81

4.8

4.0

1.71

mmol/l

0.00

309

2054

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

260

1719

1.56

9.80

3.1

2.8

130.60

180.53

ng/l

2.43

232

1553

(46235355) HIV 1 and 2 tests - Meaningful Use set

752

6021

1.32

9.65

1.9

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

293

1999

1.51

9.55

3.9

3.3

4.43

4.65

kpa

1.34

286

1941

(3034860) Kappa light chains.free [Mass/volume] in Serum

128

706

1.84

9.51

3.2

33.34

55.44

mg/l

1.72

107

592

(3019977) pH of Arterial blood

384

2772

1.43

9.39

6.4

8.3

7.42

0.68

232

1469

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

383

2767

1.43

9.32

6.3

8.3

5.01

5.09

kpa

1.09

371

2676

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

151

2.87

9.32

1.2

1.1

2.38

9.34

nmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

135

764

1.80

9.24

1.1

7.03

6.76

eliau/ml

0.02

115

(3027801) Oxygen [Partial pressure] in Arterial blood

382

2765

1.43

9.20

6.3

8.3

12.58

12.87

kpa

0.60

371

2675

(3014111) Lactate [Moles/volume] in Serum or Plasma

315

2199

1.48

9.18

6.5

8.1

1.25

1.32

mmol/l

0.72

310

2154

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

122

674

1.84

9.04

1.3

1.4

556.39

526.42

mg/l

0.25

115

648

(3016502) Oxygen saturation in Arterial blood

342

2435

1.45

9.00

6.6

8.8

96.47

95.95

1.11

333

2360

(3006571) Granulocytes/Leukocytes in Synovial fluid

236

2.44

8.95

1.5

1.7

59.31

56.46

0.18

160

(3003396) Base excess in Arterial blood by calculation

379

2757

1.42

8.87

6.4

8.2

0.65

0.90

mmol/l

0.62

305

2303

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

150

2.82

8.84

1.1

0.99

1.16

u/l

0.96

(3019420) Tryptase [Mass/volume] in Serum or Plasma

162

2.74

8.76

1.4

1.7

11.41

9.23

ug/l

0.18

146

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

476

1.98

8.68

2.1

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

495

3783

1.36

8.62

2.3

2.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

377

2755

1.41

8.60

6.4

5.6

—

(3019060) Gas panel - Arterial blood

203

1309

1.59

8.55

4.0

5.2

—

(3009343) pH of Capillary blood

230

1536

1.53

8.30

3.6

3.5

7.42

0.20

188

1261

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

453

3434

1.37

8.29

2.2

2.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

108

591

1.85

8.28

1.3

1.6

1853.51

1038.80

e6/l

0.32

459

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

450

1.98

8.26

1.1

6.24

3.75

eliau/ml

0.30

232

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

296

2.22

8.25

1.2

1.3

—

nmol/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

235

1581

1.52

8.20

3.6

3.5

5.08

5.16

kpa

0.90

224

1522

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

387

2868

1.39

8.13

3.8

4.7

229.85

242.42

u/l

1.43

369

2739

(3012544) pH of Venous blood

340

2464

1.42

8.12

4.9

3.9

7.38

0.00

181

1412

(3033099) Centromere Ab [Titer] in Serum

3.85

7.96

1.1

—

(3024263) Appearance of Synovial fluid

110

3.02

7.88

1.2

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

495

3839

1.34

7.79

1.5

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

418

1.99

7.78

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

313

2253

1.43

7.76

1.2

158.67

149.76

u/ml

0.12

110

875

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

105

584

1.82

7.67

1.3

1.5

18.14

31.21

e6/l

0.43

422

(4024509) Urine culture

181

1169

1.58

7.60

2.1

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

358

2662

1.39

7.36

2.6

2.3

0.22

0.21

g/l

1.84

337

2520

(1001926) Buprenorphine [Presence] in Urine by Screen method

173

1115

1.58

7.34

2.4

2.0

—

(1002224) Polysomnography panel

243

1686

1.48

7.32

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

101

567

1.81

7.18

2.3

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

110

634

1.76

7.16

3.3

3.1

1.68

3.39

ratio

1.08

352

(3010838) Calcium [Moles/time] in 24 hour Urine

503

1.85

7.12

2.1

1.9

5.55

5.34

mmol/24h

0.24

450

(3011288) Drugs identified in Urine by Screen method Nominal

154

974

1.61

7.08

2.6

2.8

—

(3011985) Renin [Units/volume] in Plasma

377

1.98

7.07

1.6

1.5

36.48

65.30

mu/l

0.93

342

(44816559) Phosphatidylethanol [Mass/volume] in Blood

190

1262

1.54

7.07

1.5

1.7

0.23

0.31

mg/l

1.56

580

(3021879) Hepatitis B virus core Ab [Presence] in Serum

333

2465

1.39

7.04

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

285

2054

1.42

7.03

3.0

3.7

1.23

mmol/l

0.25

248

1764

(4062490) Immunoglobulin typing, IgG

264

2.18

7.00

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

2.49

7.00

1.4

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

189

2.40

6.93

1.5

1.4

79398.16

92792.11

e6/l

0.07

127

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

171

2.47

6.92

1.4

1.2

—

(3000991) Gas panel - Venous blood

298

2173

1.41

6.88

6.9

9.5

—

(3019225) pH of Specimen

332

2469

1.38

6.82

4.0

4.2

7.37

7.36

0.52

240

1769

(3049717) Cytology report of Urine Cyto stain

127

773

1.67

6.80

2.2

2.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

3.03

6.76

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

196

1324

1.51

6.75

3.4

3.5

1.51

1.80

mmol/l

0.51

144

994

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

179

1190

1.53

6.65

1.5

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

270

2.13

6.64

1.2

1.3

6.78

6.93

g/l

0.10

194

(3024139) IgG subclass 3 [Mass/volume] in Serum

270

2.13

6.64

1.2

1.3

0.44

0.45

g/l

0.14

197

(3006653) Thiamine [Moles/volume] in Blood

133

2.65

6.63

1.3

126.51

128.61

nmol/l

0.12

133

(3028192) IgG subclass 2 [Mass/volume] in Serum

271

2.12

6.58

1.2

1.3

3.27

3.02

g/l

0.41

199

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

417

1.89

6.50

1.1

1.47

1.49

g/l

0.16

383

(3000330) Specific gravity of Urine by Test strip

180

1206

1.52

6.46

3.2

1.02

ratio

0.29

158

1087

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

476

1.83

6.44

1.3

1.2

542.86

482.78

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.93

6.42

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

729

6096

1.25

6.32

5.2

4.7

2.60

2.29

ug/l

0.27

666

5547

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

393

1.90

6.31

1.1

3.44

2.84

0.18

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.35

6.27

1.5

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

402

1.89

6.22

1.3

1.5

—

15.00

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

472

3751

1.30

6.19

1.7

1.45

1.39

0.95

410

3370

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

118

725

1.65

6.13

1.1

1.88

2.40

u/ml

0.28

356

(3028300) Cannabinoids [Presence] in Urine

207

1444

1.46

6.11

2.5

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

123

765

1.63

6.10

1.4

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

583

1.72

6.03

3.4

3.1

57.59

57.69

0.03

583

(44813793) Dust mix specific IgE antibody measurement

189

2.29

6.03

1.2

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

458

1.81

5.99

1.2

3.86

3.76

u/ml

0.04

214

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.02

5.99

1.1

0.02

u/ml

0.06

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

182

1246

1.49

5.91

3.7

2.9

1.33

1.21

0.77

182

1235

(3027008) Opiates [Presence] in Urine

205

1439

1.45

5.86

2.4

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

180

1232

1.49

5.86

3.8

2.8

0.60

0.62

0.58

180

1223

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

354

1.91

5.83

1.3

257.72

330.13

pmol/l

1.24

311

(3000764) Benzodiazepines [Presence] in Urine

204

1433

1.45

5.82

2.5

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

345

2648

1.34

5.80

3.6

3.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

2.43

5.78

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

2.22

5.72

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

658

5496

1.24

5.71

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

473

1.77

5.69

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

473

1.77

5.69

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

202

1424

1.45

5.66

2.5

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

579

1.70

5.65

1.2

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

129

829

1.58

5.62

1.1

—

(3020891) Body temperature

155

1041

1.51

5.54

3.6

4.2

36.91

°c

0.07

155

1029

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

613

5097

1.25

5.53

1.7

—

(3016879) Cocaine [Presence] in Urine

189

1323

1.45

5.50

2.5

2.0

—

(3024928) Oxygen saturation in Venous blood

105

645

1.65

5.50

4.4

3.1

60.49

62.91

0.56

105

631

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.87

5.35

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

193

2.19

5.34

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

253

2.03

5.33

2.6

2.1

13.14

20.37

mg/l

1.48

(3026389) Candida sp identified in Specimen by Organism specific culture

380

1.83

5.32

1.4

1.3

—

(3022313) Gas panel - Capillary blood

160

1095

1.48

5.24

3.8

3.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.84

5.24

1.5

85.79

428.93

nmol/24h

0.53

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

205

1475

1.41

5.16

6.9

10.3

24.00

24.33

mmol/l

0.77

198

1452

(4027681) Cerebrospinal fluid IgG ratio and IgG index

164

2.27

5.14

1.3

1.2

0.50

0.64

ratio

1.56

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

466

1.73

5.12

1.2

1.96

2.65

u/ml

0.53

170

(3018405) Lactate [Moles/volume] in Arterial blood

114

729

1.58

5.10

3.8

3.9

1.29

1.39

mmol/l

0.58

114

718

(3020779) Urea [Moles/volume] in Serum or Plasma

301

2311

1.33

5.07

7.3

8.2

8.99

9.19

mmol/l

0.24

289

2214

(3003329) Lymphocytes/Leukocytes in Synovial fluid

185

2.18

5.03

1.4

1.5

25.06

33.99

0.76

115

(3023323) Follitropin [Units/volume] in Serum or Plasma

253

1895

1.36

5.01

1.5

1.4

24.56

29.38

iu/l

1.72

222

1633

(3035320) C reactive protein [Mass/volume] in Body fluid

202

2.09

4.80

3.6

2.4

15.12

32.09

mg/l

4.66

137

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

236

2.01

4.79

3.9

4.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.58

4.76

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

269

2052

1.34

4.74

2.6

74.59

69.00

ml/min/173m2

1.66

120

838

(3023511) Choriogonadotropin [Units/volume] in Urine

609

1.61

4.71

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

298

2312

1.32

4.67

2.1

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

179

1282

1.42

4.65

2.1

2.2

5794.87

5739.36

u/l

0.01

522

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

146

2.27

4.63

1.5

1.9

90.92

109.68

ng/l

0.74

146

(3003888) Timothy IgE Ab [Units/volume] in Serum

101

645

1.58

4.58

1.1

3.55

4.85

u/ml

0.63

334

(3002523) Influenza virus A Ag [Presence] in Specimen

104

669

1.57

4.58

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

147

2.26

4.56

1.7

1.4

12.21

13.60

u/l

0.61

142

(3006184) Hemoglobin [Mass/volume] in Capillary blood

583

1.61

4.56

2.3

2.2

133.54

130.33

g/l

0.64

456

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

220

2.01

4.55

1.0

1.1

6.08

8.13

iu/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

104

671

1.57

4.52

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

221

2.00

4.50

1.5

1.16

1.10

promille

0.10

174

(3036489) Thrombin time

155

1090

1.44

4.46

2.2

2.0

21.15

20.83

0.18

137

959

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

2.46

4.37

2.0

1.9

135.06

113.81

umol/l

0.15

(3003181) Sodium [Moles/volume] in Urine

420

1.71

4.36

1.4

58.83

62.46

mmol/l

0.32

337

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

109

718

1.54

4.34

1.9

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

775

1.51

4.33

1.2

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

124

841

1.49

4.31

3.9

3.7

24.86

24.84

mmol/l

0.02

113

779

(40761536) Microorganisms panel - Urine sediment

288

2258

1.30

4.20

4.5

3.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

129

887

1.47

4.20

2.6

2.4

183.90

188.22

0.21

124

848

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

187

2.04

4.13

1.2

1.1

—

1.07

—

(40767503) Oxygen content in Capillary blood by calculation

474

1.64

4.09

2.8

2.6

17.04

16.48

0.88

464

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

246

1895

1.32

4.09

2.0

1.9

—

(3002256) Pathology report gross observation

474

3958

1.23

4.07

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

624

1.54

3.87

1.1

1.03

1.16

u/ml

0.11

261

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2616

25137

1.18

3.86

23.5

16.9

332.79

332.36

g/l

1.76

2608

24992

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

412

1.66

3.86

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

1474

0.68

3.72

1.1

0.58

0.64

ratio

0.56

185

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

145

1045

1.40

3.70

1.3

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

607

1.53

3.69

1.1

1.10

1.48

u/ml

0.28

277

(3004119) Hemoglobin [Mass/volume] in Venous blood

197

1493

1.34

3.69

5.1

3.1

130.95

129.20

g/l

0.50

192

1451

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.12

3.65

1.1

1.9

—

213.43

—

(3002079) Sodium [Moles/time] in 24 hour Urine

116

2.25

3.64

1.4

1.2

161.42

166.19

mmol/24h

0.11

116

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

164

1211

1.37

3.63

1.7

3.81

4.43

mg/l

0.40

124

875

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

143

2.11

3.58

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

563

4843

1.19

3.56

4.2

3.9

22.30

21.63

0.42

243

2131

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

449

3781

1.22

3.55

3.0

2.9

0.68

0.74

ug/l

0.72

260

2240

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

264

1.79

3.51

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

124

878

1.43

3.51

1.9

1.8

—

(3003694) ABO and Rh group [Type] in Blood

969

8718

1.16

3.51

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

464

1.59

3.47

1.1

—

(3028433) Virus identified in Specimen by Culture

2.48

3.46

1.4

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

400

3346

1.22

3.39

5.3

4.6

32.46

32.32

0.09

277

2273

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

174

1.96

3.38

1.1

1.2

1.07

1.05

ratio

0.39

144

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.51

3.37

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

246

1.80

3.36

1.2

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

210

1.87

3.35

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

445

1.59

3.33

1.1

120.22

116.62

0.38

411

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

2.04

3.30

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

161

1206

1.35

3.29

1.6

1.7

251.66

305.84

mu/l

3.25

153

1094

(3012501) Base excess in Blood by calculation

496

1.54

3.24

4.0

3.8

1.98

2.67

mmol/l

2.09

332

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

370

1.63

3.24

1.3

7.31

7.25

mmol/l

0.05

331

(3020717) Zinc [Moles/volume] in Serum or Plasma

184

1.91

3.23

1.7

1.4

19.77

21.94

umol/l

0.21

168

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.39

3.22

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

3.54

3.19

1.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.34

3.19

1.6

2.96

5.10

mg/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

451

1.56

3.17

1.2

1.3

—

(3042517) Benzodiazepines panel - Urine

4.51

3.11

3.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

123

892

1.39

3.09

1.5

1.4

9.57

10.77

u/l

0.51

720

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

480

1.53

3.03

1.6

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

118

855

1.39

2.99

1.3

521.67

956.92

titre

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

106

754

1.42

2.98

3.2

3.0

0.30

0.35

iu/ml

1.16

405

(3023410) Appearance of Cerebral spinal fluid

279

1.69

2.96

1.3

1.8

—

(4268621) Lupus anticoagulant assay

333

1.63

2.95

2.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

366

1.59

2.89

1.9

1.8

1.53

1.61

mmol/l

0.53

355

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.70

2.88

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

290

1.66

2.84

1.2

64.28

64.67

u/l

0.01

255

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

580

1.46

2.79

1.4

1.5

162.99

145.02

au/ml

0.99

158

(3007566) Smooth muscle Ab [Titer] in Serum

118

867

1.37

2.77

1.3

75.88

128.64

titre

0.80

(21491868) Cryoglobulin [Mass/volume] in Serum

2.17

2.76

1.1

1.2

—

0.20

g/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

188

1.82

2.74

2.3

2.0

—

(3037121) Protein [Mass/volume] in Urine

120

887

1.37

2.72

3.1

3.7

304.05

580.27

mg/l

1.35

413

(44806071) Cardiolipin IgM antibody measurement

3.24

2.72

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

175

1.84

2.68

1.7

1.5

2.22

7.14

u/l

3.91

146

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

147

1125

1.32

2.66

1.3

199.73

226.24

miu/ml

0.36

551

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

258

1.68

2.64

1.0

1.1

286.89

290.55

mg/l

0.14

237

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

229

1.71

2.59

1.2

1.1

17.85

15.94

u/ml

0.17

121

(4195642) Thrombophilia screening test

443

1.50

2.55

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

246

1.67

2.53

2.3

3.3

63.15

56.88

1.25

215

(3023419) Bacteria identified in Sputum by Culture

301

1.60

2.50

3.1

3.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.98

2.48

1.3

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

630

1.41

2.45

1.4

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

167

1.80

2.40

1.3

—

901.11

—

(3007463) Buprenorphine [Presence] in Urine

5.01

2.40

16.0

4.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

141

1092

1.30

2.38

1.6

1.9

1.67

1.54

g/l

0.75

119

948

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

1.72

2.35

3.5

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

510

1.44

2.33

1.0

1.1

2.80

4.58

u/ml

0.75

216

(21494890) Protein electrophoresis panel - 24 hour Urine

206

1.71

2.33

1.7

2.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.22

2.30

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.22

2.30

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.95

2.28

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

246

1.63

2.27

1.2

115.92

112.22

pmol/l

0.16

246

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

293

1.58

2.27

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

115

873

1.33

2.25

2.1

3.18

10.36

iu/l

0.61

378

(3028679) Herpes simplex virus Ab [Presence] in Serum

164

1.77

2.22

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.34

2.21

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

272

1.59

2.20

1.1

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.41

2.19

1.8

1.2

38.50

40.04

g/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

296

1.56

2.19

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

336

1.53

2.19

1.6

1.7

310.95

376.19

mu/l

0.87

272

(3008295) Osmolality of Serum or Plasma

273

1.58

2.17

1.4

1.6

275.07

281.68

mosm/kgh2o

1.08

216

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

468

1.44

2.17

1.0

0.11

0.21

u/ml

0.71

139

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

297

1.56

2.16

1.5

—

(3047181) Lactate [Moles/volume] in Blood

697

1.36

2.16

5.5

6.4

1.18

1.35

mmol/l

1.33

607

(40762887) Creatinine [Moles/volume] in Blood

4.29

2.15

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.62

2.14

1.3

2.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

298

1.55

2.13

1.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.78

2.13

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

152

1.78

2.11

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

378

3290

1.17

2.11

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.21

2.10

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

317

1.52

2.06

1.5

—

(4198724) Urine methamphetamine measurement

132

1.82

2.03

2.2

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

139

1101

1.27

2.02

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

706

1.34

2.01

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

683

1.34

1.96

1.7

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

370

1.47

1.96

1.3

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

3.75

1.93

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

556

1.38

1.93

2.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

180

1.67

1.91

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

506

1.39

1.91

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

315

1.50

1.90

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

315

1.50

1.90

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.01

1.90

1.2

1.4

93.22

89.84

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

406

1.44

1.89

1.5

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

340

1.48

1.89

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

550

1.37

1.88

1.0

1.1

2.78

3.03

u/ml

0.08

267

(3016650) Hepatitis A virus Ab [Presence] in Serum

516

1.38

1.88

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

212

1.61

1.88

1.1

1.0

0.15

3.30

u/ml

0.96

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.19

1.88

1.0

1.1

1.48

1.77

umol/24h

—

(3004809) Band form neutrophils/Leukocytes in Blood

407

1.43

1.87

2.9

3.4

0.84

1.64

2.48

370

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.09

1.86

1.1

—

(1616796) Gas panel - Central venous blood

526

1.38

1.85

4.2

3.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.21

1.84

1.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

206

1.61

1.82

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

352

1.46

1.80

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

352

1.46

1.80

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

352

1.46

1.80

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

352

1.46

1.80

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

124

985

1.27

1.79

2.1

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

581

1.35

1.79

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

138

1.74

1.79

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

119

942

1.27

1.77

4.1

3.5

1.31

1.44

mg/l

1.62

110

882

(3000093) Morphology [Interpretation] in Blood Narrative

224

1.57

1.76

1.3

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.94

1.74

1.2

1.1

91.33

91.16

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.50

1.74

1.8

0.27

0.17

nmol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

507

1.37

1.73

1.6

1.4

26.96

28.58

u/l

0.16

417

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

257

1.52

1.73

1.2

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.14

1.71

1.2

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

250

1.53

1.70

2.0

4.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

113

896

1.27

1.68

2.0

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

409

1.40

1.66

1.9

2.2

6.35

6.83

umol/l

0.10

304

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

773

1.29

1.66

3.0

2.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.58

1.66

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

598

1.33

1.65

1.5

1.4

0.30

0.40

nmol/l

1.14

450

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.80

1.65

1.3

3.9

—

(3037756) Immunofixation for Serum or Plasma

445

1.38

1.62

1.4

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.38

1.61

1.2

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.59

1.1

1.3

62.25

67.84

ug/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.00

1.59

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

1.59

1.1

—

(3020491) Glucose [Moles/volume] in Blood

199

1.56

1.6

1.9

6.06

6.63

mmol/l

1.00

132

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

137

1.68

1.55

1.1

1.7

—

(3006245) CD3-CD19+ cells/cells in Blood

100

1.80

1.53

5.4

2.4

10.22

7.76

0.25

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

609

0.70

1.52

2.9

4.0

24.53

28.61

u/ml

0.28

589

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.44

1.47

2.3

1.5

—

(4146454) Self-monitoring of blood glucose

251

1.48

1.47

3.0

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

591

0.71

1.44

4.8

3.2

22.90

26.37

mg/l

0.33

406

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.12

1.44

1.0

1.5

109.73

98.37

0.74

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

621

1.30

1.44

4.9

6.4

129.09

760.02

iu/ml

1.66

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

125

1.68

1.43

1.1

92.07

94.72

0.13

102

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.70

1.41

1.1

1.0

—

(3012898) Urea [Moles/volume] in Urine

2.42

1.39

1.4

309.86

151.25

mmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.77

1.38

3.8

5.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

305

1.42

1.38

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.61

1.36

2.2

1.5

1.83

mg/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

691

1.27

1.33

1.8

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

276

1.42

1.28

2.2

2.3

32.77

32.56

0.14

276

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.27

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

1.23

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.91

1.22

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.63

1.21

2.4

2.1

4.64

2.48

mg/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

101

1.69

1.19

1.2

1.7

41.57

40.50

g/l

0.30

101

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.88

1.18

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.88

1.18

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.88

1.18

1.1

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.50

1.15

1.6

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.73

1.15

2.6

2.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.81

1.15

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.81

1.15

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.81

1.15

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.81

1.15

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

283

1.38

1.14

1.6

1.8

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

1.14

0.0

1.9

—

1.51

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

216

1.44

1.13

3.6

2.0

12.52

15.00

0.88

211

(3017569) Oxygen content in Arterial blood

135

1.56

1.11

5.0

2.5

14.30

16.47

1.56

135

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

283

3146

0.89

1.11

1.8

1.7

3.49

3.51

mmol/l

0.09

200

2132

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

128

1.57

1.08

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

496

1.28

1.08

1.8

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.69

1.07

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.65

1.06

2.1

1.4

0.50

e9/l

0.02

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

113

1.60

1.05

1.0

6.94

11.07

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

525

1.26

1.05

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

410

1.30

1.04

2.4

3.0

4.38

692.53

u/ml

0.57

405

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

289

1.35

1.03

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.06

1.02

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

762

1.21

1.02

1.6

1.5

211.79

174.26

pmol/l

0.10

747

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

138

1599

0.86

1.01

1.4

1.6

1021.21

1025.58

mu/l

0.02

111

1318

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

555

1.25

1.01

1.8

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

256

1.37

1.00

2.3

3.0

19.50

13.51

index

0.91

170

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

343

1.32

0.99

1.7

—

(3004451) EKG impression Narrative

131

1.53

0.99

1.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

432

1.28

0.98

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

174

0.57

0.96

1.2

1.1

—

(44806420) Estimation of glomerular filtration rate

390

1.29

0.95

2.3

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

259

1.36

0.95

1.6

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

562

1.23

0.92

2.2

2.1

0.89

0.85

nmol/l

0.20

483

(3000012) Reticulocyte production index

304

1.32

0.92

3.5

2.3

1.04

0.90

0.55

194

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

296

1.32

0.90

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.07

0.89

1.3

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

266

0.67

0.89

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

538

1.23

0.88

1.5

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

359

1.29

0.88

1.6

1.9

—

974.55

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

152

1.45

0.88

1.2

6.95

9.49

mm/h

1.13

152

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

934

0.83

0.87

1.5

63.78

59.43

ug/l

0.40

767

(40768793) Breast Pathology biopsy report

102

869

1.18

0.87

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.59

0.84

1.0

1.2

—

23.90

—

(3034426) Prothrombin time (PT)

1.56

0.84

1.1

27.33

28.26

0.44

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.78

0.84

4.9

7.5

71.63

68.97

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

222

1.35

0.83

1.1

1.2

—

88.79

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

129

1.48

0.83

1.4

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

129

1.48

0.83

1.4

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1057

0.85

0.82

1.4

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.74

0.82

1.1

1.2

38.02

35.66

mg/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.88

0.81

1.3

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.88

0.81

2.3

2.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

130

1.46

0.80

1.7

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

147

1299

1.14

0.79

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

750

0.82

0.79

1.5

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.79

1.3

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.78

1.0

1.1

7.10

9.34

u/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

449

1.23

0.76

1.7

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

745

0.83

0.75

1.3

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

306

2828

1.09

0.74

3.7

4.6

29.78

30.41

ug/l

0.01

246

2240

(3044242) Glucose [Moles/volume] in Arterial blood

141

1.42

0.74

7.3

2.3

7.44

8.81

mmol/l

1.14

141

(21494434) Karyotype in Bone marrow

201

1.35

0.74

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.84

0.73

2.1

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

732

0.83

0.73

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

424

1.23

0.73

4.0

6.2

339.83

382.73

umol/l

1.31

371

(3006462) Nitrate [Presence] in Urine

100

1.50

0.72

5.3

2.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.00

0.72

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.80

0.72

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

719

0.83

0.71

1.4

1.5

1.24

1.28

0.41

505

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

134

1.42

0.71

1.7

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

216

1972

1.10

0.69

1.8

1.7

—

(40768806) Pleura Pathology biopsy report

248

1.29

0.68

1.8

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

0.68

2.0

2.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.85

0.68

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.67

0.68

1.1

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

390

4154

0.93

0.67

2.0

3.44

3.48

ratio

0.27

302

3130

(4211845) Urine protein measurement

111

1.44

0.65

5.0

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

241

1.29

0.65

2.5

2.8

—

(4015189) Microbial culture of sputum

1.59

0.65

6.9

2.2

—

(40768795) Lymph node Pathology biopsy report

326

0.77

0.63

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

225

1.29

0.63

1.6

1.4

5.82

6.22

mmol/l

0.41

216

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

333

1.23

0.62

1.8

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

637

1.17

0.61

1.2

208.96

285.77

u/ml

2.35

391

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

217

1.29

0.61

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

217

1.29

0.61

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

217

1.29

0.61

1.4

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

1.30

0.60

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.60

0.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.57

0.60

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

119

1062

1.12

0.60

1.3

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.60

0.0

12.7

—

166.79

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

500

1.18

0.59

1.1

22.52

1254.91

iu/ml

0.54

107

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

308

1.24

0.59

5.0

6.0

178.11

53.47

u/ml

0.47

(3020876) Protein [Mass/time] in 24 hour Urine

290

1.24

0.59

1.7

2.5

1.28

1.59

g/24h

0.25

182

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

573

0.84

0.58

1.3

1.5

61.81

60.72

ug/l

0.07

573

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

391

1.20

0.58

1.9

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

301

1.23

0.56

1.7

1.4

30.48

32.56

g/l

0.45

276

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

207

0.72

0.56

1.8

2.0

2.63

1.73

u/field

—

116

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.62

0.55

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

858

0.87

0.55

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

868

0.87

0.54

1.4

1.5

1.24

1.13

ratio

0.40

521

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

868

0.87

0.54

1.4

1.5

1.23

1.20

ratio

0.06

524

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

868

0.87

0.54

1.4

1.5

1.06

0.96

ratio

1.30

521

(3042631) Mycobacterium sp identified in Specimen

312

1.22

0.54

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

534

1.16

0.53

1.7

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

242

1.24

0.51

1.8

1.4

36914.24

57544.19

e6/l

0.34

127

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

206

1.26

0.51

2.3

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

215

1.26

0.50

1.0

0.67

0.80

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.45

0.48

1.5

7.80

9.01

ug/l

0.69

(4034850) Laboratory test

786

1.12

0.47

12.0

8.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

272

1.22

0.47

1.8

1.4

1461.32

1606.82

e6/l

0.10

186

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

541

1.15

0.47

2.4

2.5

59.60

85.03

ug/min

0.41

325

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

120

1.33

0.46

1.1

238.92

203.56

iu/ml

0.17

120

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.38

0.46

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.38

0.46

1.5

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.43

0.45

1.1

1.2

4.21

9.40

pmol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.40

0.45

1.4

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

404

1.17

0.44

3.1

3.4

0.78

0.79

nmol/l

0.08

326

(3017509) Phencyclidine [Presence] in Urine

1.56

0.42

3.8

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

1.40

0.42

1.1

1.3

65.42

56.35

mu/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

203

1.23

0.42

1.0

2.28

2.07

u/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

140

1.29

0.42

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

44.73

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.39

0.40

2.5

1.3

—

(3045788) Cell count panel - Pleural fluid

232

1.21

0.39

1.8

1.4

—

(3045142) Bone marrow Pathology biopsy report

306

1.18

0.39

1.2

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

0.68

0.39

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

205

1.22

0.39

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.39

0.0

2.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

448

1.14

0.38

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

317

1.17

0.37

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

107

1.31

0.37

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.39

0.37

2.9

3.3

107.60

151.85

ng/l

—

(3012441) Differential panel - Pleural fluid

235

1.19

0.36

1.8

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.40

0.35

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.40

0.35

2.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.40

0.35

2.5

1.5

—

(21494755) Public health laboratory ask at order entry panel

350

3648

0.95

0.35

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.37

0.34

3.2

3.4

50.40

45.07

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.37

0.34

6.4

6.9

9.50

7.95

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

658

0.89

0.34

1.7

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.34

6.2

3.4

11.27

10.49

kpa

0.49

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.34

6.3

3.4

4.25

4.92

kpa

1.32

(40768800) Prostate Pathology biopsy report

361

0.86

0.33

1.1

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

191

1.21

0.33

11.4

12.3

0.58

0.62

mmol/l

0.42

171

(1761482) Bacteria [#/volume] in Urine by Culture

569

1.11

0.32

4.8

3.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

143

0.77

0.32

2.5

135.00

145.97

nmol/l

0.08

126

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.31

0.31

1.1

—

(3020650) Glucose [Presence] in Urine

0.73

0.30

2.1

1.4

0.00

0.03

estimate

—

(3014271) Vancomycin [Susceptibility]

1.31

0.30

3.0

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

1.21

0.29

2.3

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

110

0.73

0.28

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

149

1.21

0.27

1.0

1.1

1519.90

1393.35

miu/ml

0.15

149

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

116

0.78

0.27

3.9

3.7

2.78

1.49

—

116

(3017704) Immunofixation for Urine

113

1.24

0.26

1.3

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.19

0.26

1.1

1.4

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

443

1.11

0.26

2.7

2.5

13.22

13.11

0.35

436

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

0.85

0.25

1.2

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

207

1.16

0.25

1.8

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.20

0.25

3.0

3.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

359

0.89

0.23

1.2

—

(4133840) Spirometry

1.27

0.22

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

6.0

—

475.79

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.25

0.20

1.3

3.0

2.17

77.35

ug/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

202

1.14

0.20

1.5

1.3

139.84

159.23

pmol/l

0.22

202

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

101

958

1.06

0.19

2.1

2.0

2.17

2.36

ug/l

0.05

876

(40765096) Chromosome analysis panel by Banding

1.22

0.19

1.1

1.2

—

(40768441) Liver Pathology biopsy report

241

1.12

0.19

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.13

0.18

1.3

1.6

1.22

1.18

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

269

0.89

0.18

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.19

0.18

1.9

1.2

2.39

2.84

mmol/l

—

(3026250) Tacrolimus [Mass/volume] in Blood

153

0.85

0.18

50.4

39.9

6.66

7.42

ug/l

1.04

139

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.6

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

413

0.92

0.17

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

253

1.11

0.16

3.1

2.2

3.94

4.01

mmol/l

0.51

246

(3035285) Chloride [Moles/volume] in Venous blood

253

1.11

0.16

3.1

2.2

106.46

105.13

mmol/l

1.30

246

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

453

0.93

0.16

1.3

1.4

2.71

3.84

ug/l

0.93

402

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.13

0.16

1.5

2.3

13.68

18.10

umol/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.15

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

102

1.18

0.15

2.8

2.6

0.60

0.62

mmol/l

0.27

102

(1761868) Lipid panel - Serum or Plasma

1314

13028

1.01

0.14

3.1

2.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

131

1.15

0.14

2.4

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

170

1.12

0.13

1.0

1019.92

692.78

ng/l

2.42

121

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

151

1.13

0.13

2.4

1.5

—

(3024932) HLA-DR beta [Type]

107

0.84

0.13

1.0

1.1

—

(3024471) HLA-A [Type]

109

0.83

0.13

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

248

1.09

0.12

3.2

2.2

1.20

1.19

mmol/l

1.13

241

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

171

1.11

0.12

1.0

249.38

336.56

ng/l

0.85

124

(3006442) Creatine [Moles/volume] in Serum or Plasma

181

1.11

0.12

1.6

1.4

73.05

77.98

umol/l

0.32

181

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

172

1.11

0.11

1.0

21.58

45.09

ng/l

4.67

122

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.16

0.11

1.3

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

192

1.09

0.10

2.2

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

154

1.10

0.10

2.6

1.5

—

783425.00

iu/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1001

0.97

0.09

4.2

4.1

797.38

658.73

u/ml

0.08

868

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

145

1.10

0.09

2.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.09

4.4

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

155

1.10

0.09

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.09

2.3

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

127

1.10

0.08

1.4

1.8

30.21

29.55

0.06

127

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.07

0.07

1.1

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

373

1.05

0.07

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

132

0.91

0.06

1.7

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

218

1.06

0.05

1.3

1.1

—

(4035726) Immunohistochemistry procedure

263

2657

0.99

0.05

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

152

1.05

0.02

4.1

3.0

40.60

42.88

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

212

1.04

0.02

7.6

7.4

19.00

41.02

ug/l

0.56

138

(3047189) Immunofixation for 24 hour Urine

103

1.07

0.02

1.9

2.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

123

1.06

0.01

1.5

1.8

1.88

4.46

u/field

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

104

1.06

0.01

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

104

1.06

0.01

1.7

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

104

1.06

0.01

1.8

2.1

—

(3042733) HLA Ab [Presence] in Serum

116

0.95

0.00

6.6

4.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

184

1.03

0.00

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

198

1.01

0.00

1.3

1.5

—

(3013762) Body weight Measured

0.00

0.0

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

10.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.96

-0.00

1.1

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

-0.00

1.0

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

-0.00

1.4

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.91

-0.00

1.0

67.14

33.57

iu/ml

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

26.40

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

301.00

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

5.9

—

1.04

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

730

1.00

-0.00

1.5

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2261.80

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

32.00

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

8.8

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

5.4

—

(40758292) HTLV I+II Ab panel - Serum

0.86

-0.00

1.2

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.63

—

(3044007) Cell count panel - Peritoneal fluid

0.90

-0.00

1.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.4

—

4.51

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

161.11

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ENTESOPATHYLOWNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.184 [1.06, 1.33]	0.004
Birth year	0.991 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 1019 out of 9037 females with M13_ENTESOPATHYLOWNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.203 [1.06, 1.36]	0.003
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 689 out of 5860 males with M13_ENTESOPATHYLOWNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_ENTESOPATHYLOWNAS.

N-year risk	Females	Males
1	0.101%	0.218%
5	0.636%	1.265%
10	1.486%	3.29%
15	2.856%	6.41%
20	5.179%	10.96%

Relationships between endpoints

↥

Index endpoint: M13_ENTESOPATHYLOWNAS – Other/unspecified enthesopathies of lower limb, excluding foot

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other/unspecified enthesopathies of lower limb, excluding foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints